Bicocca Open Archive

Logo unimib boa
VETTORETTI, SIMONE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.562
NA - Nord America 2.555
EU - Europa 1.352
SA - Sud America 909
Continente sconosciuto - Info sul continente non disponibili 263
AF - Africa 101
OC - Oceania 2
Totale 9.744
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.418
SG - Singapore 1.311
VN - Vietnam 875
CN - Cina 826
BR - Brasile 642
HK - Hong Kong 613
IT - Italia 600
BD - Bangladesh 344
RU - Federazione Russa 308
KR - Corea 162
DE - Germania 111
AR - Argentina 110
FR - Francia 102
IN - India 101
IQ - Iraq 53
CA - Canada 52
FI - Finlandia 45
EC - Ecuador 42
ID - Indonesia 40
GB - Regno Unito 39
PK - Pakistan 38
ZA - Sudafrica 37
CO - Colombia 35
MX - Messico 34
NL - Olanda 34
TR - Turchia 34
VE - Venezuela 24
UZ - Uzbekistan 21
JP - Giappone 20
UA - Ucraina 20
PH - Filippine 19
MY - Malesia 18
SE - Svezia 17
AT - Austria 15
CL - Cile 14
PY - Paraguay 14
PE - Perù 13
KE - Kenya 12
PL - Polonia 12
SA - Arabia Saudita 12
TN - Tunisia 12
JM - Giamaica 11
EG - Egitto 9
MA - Marocco 9
UY - Uruguay 9
CR - Costa Rica 8
ET - Etiopia 7
IE - Irlanda 7
KG - Kirghizistan 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
NP - Nepal 6
AZ - Azerbaigian 5
ES - Italia 5
HN - Honduras 5
JO - Giordania 5
KZ - Kazakistan 5
LB - Libano 5
RS - Serbia 5
AL - Albania 4
BG - Bulgaria 4
BO - Bolivia 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
MM - Myanmar 4
NI - Nicaragua 4
OM - Oman 4
SV - El Salvador 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
BB - Barbados 3
CI - Costa d'Avorio 3
IL - Israele 3
LT - Lituania 3
PA - Panama 3
PS - Palestinian Territory 3
QA - Qatar 3
RO - Romania 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
KH - Cambogia 2
KW - Kuwait 2
AM - Armenia 1
BS - Bahamas 1
BT - Bhutan 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
Totale 9.469
Salva come PNG Salva come JPEG
Città #
Singapore 677
Hong Kong 609
San Jose 344
Hefei 339
Ashburn 327
Ho Chi Minh City 269
Hanoi 235
Milan 165
Seoul 161
Dallas 154
The Dalles 104
Chicago 103
New York 85
Los Angeles 82
Council Bluffs 77
Lauterbourg 76
Rome 72
Buffalo 70
Boardman 53
Frankfurt am Main 53
São Paulo 53
Santa Clara 47
Moscow 38
Ann Arbor 37
Beijing 27
Da Nang 26
Haiphong 25
Turin 25
Baghdad 23
Seattle 21
Curitiba 20
Figino 20
Biên Hòa 18
Orem 18
Tashkent 18
Houston 17
Lappeenranta 17
Naples 17
Thái Nguyên 17
Denver 16
Quận Bình Thạnh 16
Quận Một 16
Rio de Janeiro 16
Brasília 15
Dhaka 15
Munich 15
Thái Bình 15
Helsinki 14
Phoenix 14
Toronto 14
Vũng Tàu 14
Can Tho 13
Guayaquil 13
Medellín 13
Mexico City 13
Tokyo 13
Turku 13
Bologna 12
Ha Long 12
Lahore 12
Nairobi 12
Quito 12
Washington 12
Wenzhou 12
Atlanta 11
Belo Horizonte 11
Delhi 11
Jakarta 11
Salvador 11
San Francisco 11
Amsterdam 10
Campinas 10
Hải Dương 10
Johannesburg 10
London 10
Shanghai 10
Xiamen 10
Bogotá 9
Erbil 9
Genoa 9
Guangzhou 9
Huế 9
Brooklyn 8
Buenos Aires 8
Istanbul 8
Miami 8
Ninh Bình 8
Palermo 8
Phủ Lý 8
Salt Lake City 8
São Gonçalo 8
Warsaw 8
Asunción 7
Chandler 7
Charlotte 7
Chennai 7
Dublin 7
Montevideo 7
Montreal 7
New Delhi 7
Totale 5.198
Salva come PNG Salva come JPEG
Nome #
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial 351
Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis 304
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial 208
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 191
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy (Journal of Nephrology, (2023), 36, 7, (2013-2022), 10.1007/s40620-023-01708-7) 184
Peritoneal dialysis related peritonitis: insights from a long-term analysis of an Italian center 180
Sarcopenia in Chronic Kidney Disease: Focus on Advanced Glycation End Products as Mediators and Markers of Oxidative Stress 179
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 179
Changes in 24-hour blood pressure profile after 12 weeks of dapagliflozin treatment in patients with diabetic kidney disease: An Italian multicenter prospective study 176
Poor Nutritional Status Is Associated with Death in a Population of Dialyzed Older Persons 166
Associations of Intact and C-Terminal FGF23 with Inflammatory Markers in Older Patients Affected by Advanced Chronic Kidney Disease 158
Relationship between number of daily exchanges at CAPD start with clinical outcomes 156
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 152
Simultaneous removal and replacement of the peritoneal catheter in CAPD patient with refractory peritonitis sustained by P. aeruginosa: A case-report 152
What Not to Overlook in the Management of Patients with Type 2 Diabetes Mellitus: The Nephrological and Hepatological Perspectives 151
Palliative and Supportive Dialysis: Current Practices and Recommendations for Best Clinical Practice 147
Serum uric acid and target organ damage in primary hypertension 145
Spontaneous low-protein intake in older CKD patients: one diet may not fit all 143
Importance of blood pressure control in chronic kidney disease 142
Frailty Is Associated with Malnutrition–Inflammation Syndrome in Older CKD Patients 141
Clinical Factors and Biomarkers Associated with Depressive Disorders in Older Patients Affected by Chronic Kidney Disease (CKD): Does the Advanced Glycation End Products (AGEs)/RAGE (Receptor for AGEs) System Play Any Role? 135
Corrigendum: Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study (Frontiers in Medicine, (2023), 10, (1221086), 10.3389/fmed.2023.1221086) 132
Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease 132
What's New in the CKD-BMD Therapy? 132
Association between the uremic toxins indoxyl-sulfate and p-cresyl-sulfate with sarcopenia and malnutrition in elderly patients with advanced chronic kidney disease 124
Palliative and supportive dialysis: State of the art and recommendations for good clinical practice 124
Can Mediterranean Diet Have a Positive Impact on Kidney Health? A Pending Answer to a Long-Time Question 122
Possible Benefits of a Low Protein Diet in Older Patients With CKD at Risk of Malnutrition: A Pilot Randomized Controlled Trial 122
A new CHA2DS2VASC score integrated with estimated glomerular filtration rate, left ventricular hypertrophy, and pulse pressure is highly effective in predicting adverse cardiovascular outcome in chronic kidney disease 120
The Number of Medications Is Associated with Fractures in a Population of Dialyzed Older Patients with Frailty 120
Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction 117
Native vitamin D in CKD and renal transplantation: meaning and rationale for its supplementation 111
Advanced glycation end products (Age) and soluble forms of age receptor: Emerging role as mortality risk factors in CKD 110
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 108
MCP1 Could Mediate FGF23 and Omega 6/Omega 3 Correlation Inversion in CKD 106
Association between Advanced Glycation End-Products and Sarcopenia in Patients with Chronic Kidney Disease 105
Endothelial dysfunction in chronic kidney disease: Determinant of susceptibility to end-organ damage and therapeutic response 101
Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress 100
Optimizing global risk evaluation in primary hypertension: The role of microalbuminuria and cardiovascular ultrasonography 98
Frailty phenotype and multi-domain impairments in older patients with chronic kidney disease 98
Calcium carbonate-enriched cheese to improve nutrition, compliance and phosphorus control in patients on kidney replacement therapy 97
Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease 97
Nutritional Strategies to Prevent Muscle Loss and Sarcopenia in Chronic Kidney Disease: What Do We Currently Know? 97
Beyond cohort selection: An analytics-enabled i2b2 96
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension 96
Microalbuminuria, cardiovascular, and renal risk in primary hypertension 95
Frailty index and adverse outcomes in older patients in haemodialysis 95
Role of vitamin E-coated membrane in reducing advanced glycation end products in hemodialysis patients: A pilot study 95
Vitamin D and Calcium Supplementation and Urolithiasis: A Controversial and Multifaceted Relationship 94
Plasma adiponectin levels in chronic kidney disease patients: Relation with molecular inflammatory profile and metabolic status 93
Economic evaluation of angiotensin receptor blockers in type 2 diabetes, hypertension, and nephropathy 92
Use of the Frailty Index in Older Persons With Chronic Kidney Disease 90
Impact of hyperparathyroidism and its different subtypes on long term graft outcome: a single Transplant Center cohort study 88
Vulvar pyoderma gangrenosum with renal involvement 88
Metabolic acidosis in renal transplantation: neglected but of potential clinical relevance 87
Patients with Hypertensive Nephropathy and Chronic Kidney Disease Might Not Benefit from Strict Blood Pressure Control 87
Pulse pressure and subclinical cardiovascular damage in primary hypertension 87
Vitamin D and subclinical cardiac damage in a cohort of kidney transplanted patients: a retrospective observational study 85
In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition 84
Mild Renal Dysfunction and Cardiovascular Risk in Hypertensive Patients 84
MCP1 Inverts the Correlation between FGF23 and Omega 6/3 Ratio: Is It Also True in Renal Transplantation? 84
Association of Autofluorescent Advanced Glycation End Products (AGEs) with Frailty Components in Chronic Kidney Disease (CKD): Data from a Single-Center Cohort Study 84
Changes over time in ambulatory blood pressure and cardiac parameters predict cardiovascular outcome of patients with CKD and low cardiovascular morbidity 83
Malnutrition and inflammation are associated with severity of depressive and cognitive symptoms of old patients affected by chronic kidney disease 81
Associations Between Cholesterol and Fatty Acid Profile on the Severity of Depression in Older Persons With Nondialysis Chronic Kidney Disease 80
Altered myogenic constriction and endothelium-derived hyperpolarizing factor-mediated relaxation in small mesenteric arteries of hypertensive subtotally nephrectomized rats 80
Mild renal dysfunction and renal vascular resistance in primary hypertension 80
Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice 79
The Importance of Adherence in the Treatment of Secondary Hyperparathyroidism 79
Calcium and osteoprotegerin levels predict the progression of the abdominal aortic calcifications after kidney transplantation 79
Frailty in kidney transplantation: a review on its evaluation, variation and long-term impact 78
Prevention and treatment of diabetic nephropathy: The program for Irbesartan mortality and morbidity evaluation 78
Sarcopenia is associated with malnutrition but not with systemic inflammation in older persons with advanced CKD 78
Is there an association between severity of illness and psychiatric symptoms in patients with chronic renal failure? 77
Renal and cardiovascular protection in type 2 diabetes mellitus: Angiotensin II receptor blockers 77
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 77
Renal endothelial function is associated with the anti-proteinuric effect of ACE inhibition in 5/6 nephrectomized rats 77
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 77
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: An artificial neural network-based approach 75
The role of angiotensin II AT1 receptor antagonists in nephroprotection and cardioprotection in type 2 diabetes mellitus 74
Treatment of hyperuricemia in CKD 74
AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease 74
Creatinine clearance and signs of end-organ damage in primary hypertension 72
Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension 71
Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension 65
Cardiovascular and Renal Risk Assessment as a Guide for Treatment in Primary Hypertension 62
Totale 9.744
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.615
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202227 0 8 6 2 1 5 0 0 2 0 1 2
2022/202357 5 14 9 8 9 7 0 0 2 1 0 2
2023/202414 1 2 2 1 0 5 0 0 2 0 0 1
2024/20252.461 1 6 2 2 3 1 15 4 558 541 331 997
2025/20266.555 574 790 606 892 361 246 576 352 547 443 354 814
2026/2027566 400 166 0 0 0 0 0 0 0 0 0 0
Totale 9.744